Janwillem Naesens's Insider Trades & SAST Disclosures

Janwillem Naesens's most recent trade in Cyteir Therapeutics Inc was a trade of 14,150 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 22, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cyteir Therapeutics Inc
Janwillem Naesens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 14,150 14,150 - - Stock Option (Right to Buy)
Cyteir Therapeutics Inc
Janwillem Naesens Director 22 Jun 2021 10,000,000 0 - - Series B Convertible Preferred Stock
Cyteir Therapeutics Inc
Janwillem Naesens Director 22 Jun 2021 3,259,026 3,259,026 - - Common Stock
Cyteir Therapeutics Inc
Janwillem Naesens Director 22 Jun 2021 1,109,368 0 - - Series C Convertible Preferred Stock
Cyteir Therapeutics Inc
Janwillem Naesens Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 22 Jun 2021 277,777 3,536,803 - 18 4,999,986 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades